List of Studies ( Metabolite:SHexCer 18:1;O2/16:0)
| Study_id | Analysis_id | Study_title | Source | Species | Disease | Institute | Analysis Type |
|---|---|---|---|---|---|---|---|
| ST004451 | AN007454 | Lipidomics profiling of NMNAT2–SARM1 pathway modulation in mouse cortical neurodegeneration | Brain cortex | Mouse | Neurodegenerative disease | Indiana University Bloomington | LC-MS |
| ST004385 | AN007327 | Inducible deletion of DGAT1 and 2 from microglia exacerbates neurodegeneration and endolysosomal lipid accumulation in male PS19 mice | Brain | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004206 | AN006996 | Lipidomic Profiling of Sorted Microglia in GPR34-KO/APP-KI Mice Across 4, 8, 16, and 24 Months | Glial cells | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004205 | AN006993 | Lipidomic/Metabolomic Characterization of GPR34 KO, WT, TREM2 KO, and GPR34/TREM2 dKO iPSC1-derived microglia | Glial cells | Human | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004202 | AN006988 | Targeted lipidomics of PHACTR1 overexpressing and knockdown HT1080 stable cell lines | Cultured cells | Human | Cancer | Baker Heart and Diabetes Institute | LC-MS |
| ST004163 | AN006909 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Metabolic disease | Denali Therapeutics | LC-MS |
| ST004163 | AN006909 | Targeted Lipid Profiling of HEK and iPSC derived iMG Cell Models with GBA1 Loss-of-Function | Cultured cells | Human | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006715 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Neurodegenerative disease | Denali Therapeutics | LC-MS |
| ST004059 | AN006715 | Targeted Lipid and Metabolite Profiling in Brains of ATP13A2 Knockout Mice | Brain | Mouse | Parkinsons disease | Denali Therapeutics | LC-MS |
| ST003880 | AN006373 | Untargeted metabolome analysis of control and disease intervertebral disc tissue | Tissue | Human | Bone disease | Ganga Orthopaedic Research and Education Foundation | LC-MS |
| ST003694 | AN006061 | FOLFIRINOX effects on lipidomics in pancreatic cancer cells | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003661 | AN006017 | Lipidomics facilitates the discovery of diagnostic biomarkers in patients with chronic total occlusion during the perioperative period | Blood | Human | Cardiovascular disease | Zhongshan Hospital Fudan University | LC-MS |
| ST003637 | AN005973 | lomitapide effects on lipidomics | Pancreas | Human | Cancer | Pennsylvania State University | LC-MS |
| ST003575 | AN005870 | Lipidomic Profiling of a Preclinical Model of Streptozotocin induced Diabetic Cardiomyopathy | Blood | Mouse | Cardiovascular disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Blood | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST003472 | AN005707 | An Optimized Plasmalogen Dietary Supplement Remodels the Cardiac Lipidome and Proteome, Providing Greater Protection in a Male Mouse Model of Dilated Cardiomyopathy Over Females | Heart | Mouse | Heart disease | Baker Heart and Diabetes Institute | LC-MS |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Atria | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002939 | AN004824 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - Part 2 of 2, Mus musculus | Ventricles | Mouse | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002938 | AN004823 | Role of PI3K in Atrial Myopathy: Insights from Transgenic Mouse Models and Identification of a Dysregulated PI3K Lipid Profile in Individuals with Atrial Fibrillation - part 1 of 2, human plasma | Blood | Human | Atrial fibrillation | Baker Heart and Diabetes Institute | LC-MS |
| ST002928 | AN004802 | The major TMEM106B dementia risk allele affects TMEM106B protein levels, fibril formation, and myelin lipid homeostasis in the ageing human hippocampus | Brain | Human | Dementia | University of Sydney | LC-MS |
| ST002787 | AN004534 | Metabolomic analysis of gut metabolites in colorectal cancer patients: correlation with disease development and outcome | Feces | Human | Cancer | Wuhan University of Science and Technology | LC-MS |
| ST002403 | AN003917 | Deep multi-omic profiling reveals extensive mitochondrial remodeling driven by glycemia in early diabetic kidney disease (Mitochondria) | Mitochondria | Rat | Kidney disease | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Blood | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Epididymal fat | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Liver | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Muscle | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST002229 | AN003638 | Estrogen receptor α deficiency in cardiac myocytes reprograms heart-derived extracellular vesicle proteome and induces obesity in female mice (Part 1) | Ventricles | Mouse | Obesity | Baker Heart and Diabetes Institute | LC-MS |
| ST001953 | AN003178 | Identifying metabolite changes in human islets treated with Phospho-BAD mimicry and Inflammatory cytokines | Cultured cells | Human | Diabetes | Harvard University | MS(Dir. Inf.) |
| ST001936 | AN004932 | Pseudoexfoliation aqueous humor lipidome suggests enrichment of specific pathways | Eye tissue | Human | Pseudoexfoliation syndrome | University of Miami | LC-MS |
| ST001888 | AN003059 | A Metabolome Atlas of the Aging Mouse Brain (Study part II) | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001819 | AN002951 | EC and PVC from 14-15 month-old APOE3/3, APOE3/4 and APOE4/4 mice | Brain | Mouse | Alzheimers disease | Columbia University | LC-MS |
| ST001637 | AN002677 | A Metabolome Atlas of the Aging Mouse Brain | Brain | Mouse | University of California, Davis | GC-MS/LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001067 | AN001747 | Lipidomics analysis for aged mice femoral muscle (part - IV) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001065 | AN001743 | Lipidomics analysis for aged mice brain cortex (part-II) | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Adipose tissue | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Brain | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Liver | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001063 | AN001740 | Lipidomics analysis for aged mice organs | Muscle | Mouse | Takeda Pharmaceutical Company Limited | LC-MS | |
| ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Blood | Mouse | Baker Heart and Diabetes Institute | LC-MS | |
| ST001019 | AN001667 | Lipidomic profiling of heart and plasma of mice following swim training versus pressure overload | Heart | Mouse | Baker Heart and Diabetes Institute | LC-MS | |
| ST000047 | AN000080 | Identification of altered metabolic pathways in Alzheimer's disease, mild cognitive impairment and cognitively normals using Metabolomics (CSF) | Cerebrospinal fluid | Human | Alzheimers disease | Mayo Clinic | LC-MS |
